Standard BioTools, Inc. (LAB)
0.725
+0.03
(+4.77%)
USD |
NASDAQ |
Sep 09, 12:06
Standard BioTools Debt to Equity Ratio : 0.052 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.052 |
| March 31, 2026 | 0.0526 |
| December 31, 2025 | 0.0727 |
| September 30, 2025 | 0.0685 |
| June 30, 2025 | 0.0674 |
| March 31, 2025 | 0.0694 |
| December 31, 2024 | 0.0651 |
| September 30, 2024 | 0.1828 |
| June 30, 2024 | 0.1775 |
| March 31, 2024 | 0.1592 |
| December 31, 2023 | 0.6018 |
| September 30, 2023 | -3.120 |
| June 30, 2023 | -3.639 |
| March 31, 2023 | -4.253 |
| December 31, 2022 | 0.4467 |
| September 30, 2022 | -6.604 |
| June 30, 2022 | -11.08 |
| March 31, 2022 | 8.040 |
| December 31, 2021 | 1.180 |
| September 30, 2021 | 1.058 |
| June 30, 2021 | 0.8769 |
| March 31, 2021 | 0.7669 |
| December 31, 2020 | 0.6859 |
| September 30, 2020 | 0.6279 |
| June 30, 2020 | 0.7182 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6694 |
| December 31, 2019 | 0.3904 |
| September 30, 2019 | 0.3485 |
| June 30, 2019 | 0.3359 |
| March 31, 2019 | 0.322 |
| December 31, 2018 | 2.386 |
| September 30, 2018 | 7.556 |
| June 30, 2018 | 4.787 |
| March 31, 2018 | 3.380 |
| December 31, 2017 | 6.311 |
| September 30, 2017 | 4.995 |
| June 30, 2017 | 8.150 |
| March 31, 2017 | 5.065 |
| December 31, 2016 | 3.662 |
| September 30, 2016 | 2.867 |
| June 30, 2016 | 2.312 |
| March 31, 2016 | 1.968 |
| December 31, 2015 | 1.703 |
| September 30, 2015 | 1.576 |
| June 30, 2015 | 1.468 |
| March 31, 2015 | 1.372 |
| December 31, 2014 | 1.299 |
| September 30, 2014 | 1.264 |
| June 30, 2014 | 1.207 |
| March 31, 2014 | 1.166 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Illumina, Inc. | 0.8904 |
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Danaher Corp. | 0.5298 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 627.22M |
| Total Liabilities (Quarterly) | 87.25M |
| Shareholders Equity (Quarterly) | 539.97M |
| Current Ratio | 9.100 |
| Net Debt Paydown Yield | 0.21% |